BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li S, Zhu C, Zhou X, Chen L, Bo X, Shen Y, Guan X, Han X, Shan D, Sun L, Chen Y, Xu H, Yue W. Engineering ROS-Responsive Bioscaffolds for Disrupting Myeloid Cell-Driven Immunosuppressive Niche to Enhance PD-L1 Blockade-Based Postablative Immunotherapy. Adv Sci (Weinh) 2022;9:e2104619. [PMID: 35156339 DOI: 10.1002/advs.202104619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang D, Nie T, Huang C, Chen Z, Ma X, Fang W, Huang Y, Luo L, Xiao Z. Metal-Cyclic Dinucleotide Nanomodulator-Stimulated STING Signaling for Strengthened Radioimmunotherapy of Large Tumor. Small 2022;:e2203227. [PMID: 36026551 DOI: 10.1002/smll.202203227] [Reference Citation Analysis]
2 Chen Q, Zhou S, Ding Y, Chen D, Dahiru NS, Tang H, Xu H, Ji M, Wang X, Li Z, Chen Q, Li Y, Tu J, Sun C. A bio-responsive, cargo-catchable gel for postsurgical tumor treatment via ICD-based immunotherapy. Journal of Controlled Release 2022;346:212-25. [DOI: 10.1016/j.jconrel.2022.04.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]